7C3G image
Entry Detail
PDB ID:
7C3G
Title:
Crystal structure of human ALK2 kinase domain with R206H mutation in complex with a bicyclic pyrazole inhibitor RK-73134
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2020-05-12
Release Date:
2021-03-03
Method Details:
Experimental Method:
Resolution:
1.80 Å
R-Value Free:
0.22
R-Value Work:
0.18
Space Group:
P 21 21 2
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Activin receptor type-1
Mutations:R206H
Chain IDs:A, B
Chain Length:301
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Novel bicyclic pyrazoles as potent ALK2 (R206H) inhibitors for the treatment of fibrodysplasia ossificans progressiva.
Bioorg.Med.Chem.Lett. 38 127858 127858 (2021)
PMID: 33609658 DOI: 10.1016/j.bmcl.2021.127858

Abstact

Mutant activin receptor-like kinase-2 (ALK2) is associated with the pathogenesis of fibrodysplasia ossificans progressiva, making it an attractive target for therapeutic intervention. We synthesized a new series of bicyclic pyrazoles and evaluated their mutant ALK2 enzyme inhibitory activities, leading to the identification of 8 as the most potent inhibitor. This compound showed moderate microsomal metabolic stability and human ether-a-go-go related gene (hERG) safety. In C2C12 cells carrying mutant ALK2 (R206H), 8 efficiently inhibited the bone morphogenetic protein (BMP)-induced alkaline phosphatase activity.

Legend

Protein

Chemical

Disease

Primary Citation of related structures